Aura Biosciences secures $8 million in additional funding and augments Board of Directors and Clinical Advisory Board

por Ysios Capital

The round of financing consisted of expanded funding commitments from its existing investors: Advent Partners, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments and several individual inv...

Leer más
Subscribirse al Directorio
Escribir un Artículo

Destacadas

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology

Providence Equity Partners adquiere a Br...

by Bridges Fund Management

Bridges ha acordado vender VivaGym Group, uno de los principales opera...

Diapositiva de Fotos